Global Nucleic Acid Amplification Testing Market Trends, Analysis, Growth, and Forecast: 2018 to 2027
MarketResearch.biz delivers in-depth insights on the global nucleic acid amplification testing market in its upcoming report titled, “Global Nucleic Acid Amplification Testing Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global nucleic acid amplification testing market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global nucleic acid amplification testing market report has been segmented on the basis of technique, application, and region.
Nucleic acid amplification testing is a highly sensitive method of testing blood; it helps in detection of viral DNAs or RNAs in blood samples of patients. It is widely used in detection of bacterial & viral diseases, cancerous diseases, genetically related diseases etc. Nucleic acid amplification methods are categories into 3 types which includes target amplification systems, probe amplification systems, and signal amplification.
Increasing prevalence of viral and infectious diseases globally is expected to drive the global nucleic acid amplification testing market over the forecast period. In addition, the nucleic acid amplification testing provides the most precise detection and hence widely preferred as compared to the traditional methods thus this factor in turn is expected to drive the market growth over the forecast period. Moreover, growing demand for advanced testing methods and increasing R&D funding by biopharmaceutical industry are other factors expected to boost the growth of global nucleic acid amplification testing market over the forecast period.
However, lack of skilled professionals is a major factor restraining the growth of global nucleic acid amplification testing market over the forecast period.
Technological advancements and innovations focusing on use of nucleic acid amplification tests in various applications such as forensics, and personalized medicine is expected to create new opportunities for major players in the global nucleic acid amplification testing market over the forecast period.
North America dominates the global nucleic acid amplification testing market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the presence of potential market players and well developed healthcare infrastructure in the region. Europe accounts for second-largest revenue share contribution to the global nucleic acid amplification testing market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years. This is attributed to developing healthcare infrastructure and increasing prevalence of infectious diseases in the region.
Global nucleic acid amplification testing market segmentation, by technique:
- Target amplification systems
- Probe amplification systems
- Signal amplification
Global nucleic acid amplification testing market segmentation, by application:
- Infectious Diseases
- Personalized Medicine
- Genetic and Mitochondrial Disorders
Global nucleic acid amplification testing market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Becton, Dickinson and Company
- Hoffmann-La Roche AG
- Siemens Healthcare GmbH
- Bio-Rad Laboratories, Inc.
- bioMérieux SA
- Illumina, Inc.
- Grifols SA
- Beckman Coulter, Inc.
- Abbott Laboratories
- Hologic, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!